HEALTH CARE SECTOR

 » 

BIOTECHNOLOGY INDUSTRY

 » 

LXRX

lexicon pharmaceuticals inc
(LXRX:NASDAQ GS)

Last $2.21 USD
Change Today +0.03 / 1.38%
Volume 996.3K
LXRX On Other Exchanges
Symbol
Exchange
LXRX:US
NASDAQ GS
LX3:GR
Frankfurt
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
OverviewBoard MembersCommittees

Audit Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Connections)Board RelationshipsTitleKey Developments
Samuel Barker Ph.D. 40 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee 
Frank Palantoni B.Sc., M.B.A. 8 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee 
Judith Swain Ph.D., M.D. 43 RelationshipsDirector, Member of Audit Committee and Member of Corporate Governance Committee 

Compensation Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Connections)Board RelationshipsTitle
Philippe Amouyal 25 RelationshipsDirector and Member of Compensation Committee
Samuel Barker Ph.D. 40 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
Alan Nies M.D. 8 RelationshipsChairman of Medical Advisory Board, Director and Member of Compensation Committee
Frank Palantoni B.Sc., M.B.A. 8 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
LXRX Compensation vs. Industry
580.0K
386.8K
Chief Executive Officer
385.0K
277.0K
Chief Financial Officer
Share price activity for LEXICON PHARMACEUTICALS INC (LXRX)
52 Week Price Performance
LXRX
Industry Average

Corporate Governance Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Connections)Board RelationshipsTitle
Raymond Debbane 25 RelationshipsDirector and Member of Compensation Committee
Robert Lefkowitz M.D. 49 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
Judith Swain Ph.D., M.D. 43 RelationshipsChairman of Medical Advisory Board, Director and Member of Compensation Committee
LXRX and Competitor
Insiders vs. External
Board
22%
78%
Lexicon Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Board Relationships)/Title Board Affiliations
Alan Nies 8 Relationships
Chairman of Medical Advisory Board, Director and Member of Compensation Committee
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $2.21 USD +0.03

LXRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LXRX.
View Industry Companies
 

Industry Analysis

LXRX

Industry Average

Valuation LXRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 972.2x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 782.1x
View Detailed LXRX Financials
 | 
View Sector Analysis

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close